Obesity and younger age at gout onset in a community-based cohort

Arthritis Care and Research

Volumn 63, Issue 8, 2011, Pages 1108-1114

  DeMarco, Mara A McAdams ^a   Maynard, Janet W ^a   Huizinga, Mary Margret ^a   Baer, Alan N ^a   Köttgen, Anna ^a,b   Gelber, Allan C ^a   Coresh, Josef ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL;

ADOLESCENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GOUT; HEALTH CARE PERSONNEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; COMMUNITY-BASED PARTICIPATORY RESEARCH; COMORBIDITY; FEMALE; GOUT; HUMANS; LONGITUDINAL STUDIES; MALE; MARYLAND; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; RISK ASSESSMENT; YOUNG ADULT;

EID: 84860389295     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20479     Document Type: Article

References (25)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55.
2. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol 2002;29:2403-6. (Pubitemid 35266034)
3. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008;58:26-35.
4. Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. JAMA 1991;266:3004-7.
5. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742-8. (Pubitemid 40569426)
6. Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of female gout: fifty-two-year followup of a prospective cohort. Arthritis Rheum 2010;62:69-76.
7. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia: a long-term population study. Am J Med 1967;42:27-37.
8. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 2001;24:1522-7. (Pubitemid 33716443)
9. Lally EV, Ho G Jr, Kaplan SR. The clinical spectrum of gouty arthritis in women. Arch Intern Med 1986;146:2221-5. (Pubitemid 17189098)
10. Puig JG, Michan AD, Jimenez ML, Perez de Ayala C, Mateos FA, Capitan CF, et al. Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 1991;151:726-32.
11. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008;67:960-6. (Pubitemid 351956658)
12. Yu KH, Luo SF. Younger age of onset of gout in Taiwan. Rheumatology (Oxford) 2003;42:166-70.
13. Chen SY, Chen CL, Shen ML. Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol 2007;26:1453-7.
14. McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, Coresh J, et al. Reliability and validity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease (CLUE II) and Atherosclerosis Risk in the Community (ARIC) cohorts. J Rheumatol 2011;38:135.
15. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva: World Health Organization; 2000.
16. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994;78:25-9. (Pubitemid 24026741)
17. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008-11.
18. Dessein PH, Shipton EA, Stanwix AE, Joffe BI, Ramokgadi J. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000;59:539-43. (Pubitemid 30445833)
19. Rathmann W, Funkhouser E, Dyer AR, Roseman JM. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998;8:250-61. (Pubitemid 28208943)
20. Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfutzner A. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 1999;48:677-80. (Pubitemid 29277635)
21. Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003;44:527-36. (Pubitemid 41518990)
22. Emmerson B. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 1998;57:509-10. (Pubitemid 28474054)
23. Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord 1995;19:570-2.
24. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
25. McAdams MA, Van Dam RM, Hu FB. Comparison of selfreported and measured BMI as correlates of disease markers in US adults. Obesity (Silver Spring) 2007;15:188-96. (Pubitemid 46219799)